Rekah Pharmaceutical Industry Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Rekah Pharmaceutical Industry.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 17.7% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Here's Why Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Not Expect A Pay Rise This Year
Dec 14
Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet
Sep 12Estimating The Fair Value Of Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Jul 19Rekah Pharmaceutical Industry's (TLV:REKA) Problems Go Beyond Weak Profit
Apr 13We Think Rekah Pharmaceutical Industry (TLV:REKA) Is Taking Some Risk With Its Debt
May 12Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Might Deserve Your Attention Today
Apr 09Does Rekah Pharmaceutical Industry's (TLV:REKA) Share Price Gain of 50% Match Its Business Performance?
Mar 12Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 19
Is Rekah Pharmaceutical Industry (TLV:REKA) Using Too Much Debt?
Jan 29Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Is An Interesting Stock
Jan 08How Is Rekah Pharmaceutical Industry's (TLV:REKA) CEO Paid Relative To Peers?
Dec 18Investors Who Bought Rekah Pharmaceutical Industry (TLV:REKA) Shares Five Years Ago Are Now Up 33%
Nov 30In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Rekah Pharmaceutical Industry has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 322 | -7 | 17 | 28 | N/A |
| 9/30/2023 | 315 | -8 | 20 | 31 | N/A |
| 6/30/2023 | 309 | -3 | 21 | 30 | N/A |
| 3/31/2023 | 299 | -2 | 9 | 17 | N/A |
| 12/31/2022 | 292 | -2 | 32 | 39 | N/A |
| 9/30/2022 | 287 | 4 | 25 | 32 | N/A |
| 6/30/2022 | 275 | 3 | 33 | 42 | N/A |
| 3/31/2022 | 272 | 5 | 13 | 23 | N/A |
| 12/31/2021 | 264 | 7 | 7 | 21 | N/A |
| 9/30/2021 | 262 | 5 | 9 | 26 | N/A |
| 6/30/2021 | 273 | 9 | -14 | 3 | N/A |
| 3/31/2021 | 263 | 10 | 2 | 21 | N/A |
| 12/31/2020 | 265 | 11 | -8 | 11 | N/A |
| 9/30/2020 | 240 | 7 | -8 | 15 | N/A |
| 6/30/2020 | 221 | 5 | -4 | 33 | N/A |
| 3/31/2020 | 215 | 4 | -18 | 27 | N/A |
| 12/31/2019 | 196 | 3 | -11 | 34 | N/A |
| 9/30/2019 | 201 | 6 | -9 | 32 | N/A |
| 6/30/2019 | 195 | 5 | 14 | 40 | N/A |
| 3/31/2019 | 196 | 7 | 20 | 37 | N/A |
| 12/31/2018 | 199 | 8 | 2 | 17 | N/A |
| 9/30/2018 | 202 | 0 | -4 | 12 | N/A |
| 6/30/2018 | 206 | -8 | -8 | 10 | N/A |
| 3/31/2018 | 208 | -11 | -15 | 4 | N/A |
| 12/31/2017 | 201 | -21 | 7 | 24 | N/A |
| 9/30/2017 | 204 | -31 | N/A | 27 | N/A |
| 6/30/2017 | 208 | -22 | N/A | 23 | N/A |
| 3/31/2017 | 209 | -20 | N/A | 37 | N/A |
| 12/31/2016 | 218 | -11 | N/A | 23 | N/A |
| 9/30/2016 | 185 | 8 | N/A | 16 | N/A |
| 6/30/2016 | 195 | 8 | N/A | 8 | N/A |
| 3/31/2016 | 204 | 5 | N/A | -3 | N/A |
| 12/31/2015 | 210 | 3 | N/A | 6 | N/A |
| 9/30/2015 | 258 | -7 | N/A | 0 | N/A |
| 6/30/2015 | 259 | -7 | N/A | 13 | N/A |
| 3/31/2015 | 265 | -5 | N/A | 9 | N/A |
| 12/31/2014 | 216 | -1 | N/A | 1 | N/A |
| 9/30/2014 | 273 | 6 | N/A | 7 | N/A |
| 6/30/2014 | 269 | 7 | N/A | 4 | N/A |
| 3/31/2014 | 274 | 8 | N/A | 7 | N/A |
| 12/31/2013 | 270 | 8 | N/A | 12 | N/A |
| 9/30/2013 | 273 | 7 | N/A | 8 | N/A |
| 6/30/2013 | 277 | 6 | N/A | 11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if REKA's forecast earnings growth is above the savings rate (2%).
Earnings vs Market: Insufficient data to determine if REKA's earnings are forecast to grow faster than the IL market
High Growth Earnings: Insufficient data to determine if REKA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if REKA's revenue is forecast to grow faster than the IL market.
High Growth Revenue: Insufficient data to determine if REKA's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if REKA's Return on Equity is forecast to be high in 3 years time